Abstract
During the past decade, the focus of the pharmabiotechnology industry has shifted toward developing personalized therapeutics. Consequentially, supporting initiatives around genome sequencing and high throughput analytical technologies have lead to an irreconcilable data deluge. As a result, the sector is challenged by the lack of suitable solutions to optimize business costs through collaborative innovation across the value chain. The concept of Infrastructure as a Service or Cloud Computing demonstrates significant potential to address the twin challenges of the life sciences sector. While cloud computing has been adopted across several industries, its application in the life sciences sector remains nascent. This paper reviews the role of cloud computing in the life sciences industry and explores its potential to create disruptive opportunities for innovation and efficiency across the value chain. Further the article suggests a qualitative cloud deployment framework that could help life sciences companies maximize the potential benefits offered by the cloud.
Get full access to this article
View all access options for this article.
